Anti-malarial Drugs Market Size 2022 Global Opportunities, Trends, Share, Regional Overview, Global Growth, and Country Forecast
Malaria
is an infectious disease spread by the bite of an infected female Anopheles
mosquito, which transmits parasites into the human body. Furthermore, these
parasites enter liver cells and multiply and grow there. They then progress to
the red blood cell stage, where they are known as merozoites. These merozoites
grow inside red cells and destroy them, resulting in symptoms like fever,
tiredness, vomiting, and headache. Furthermore, antimalarial drugs are those
that are used to treat and prevent malarial infections. For the treatment of
malarial infection, various drugs are available on the market, including
quinine, chloroquine, proguanil, mefloquine, pyrimethamine, and others.
The
rise in malaria prevalence in developing countries is a major factor driving
the growth of the anti-malarial drugs market. Furthermore, increased government
awareness initiatives and increased research for new antimalarial drugs are
some of the factors driving the market growth. However, in developing countries, a
lack of awareness about healthcare is a major factor impeding the growth of the anti-malarial
drugs market.
Conversely, emerging economies' growth opportunities are expected to provide
lucrative opportunities for market expansion during the forecast period.
Malaria
infections are treated and prevented with antimalarial drugs. Human malaria is
caused by five different types of plasmodia parasites. Malaria is found in over
100 countries, primarily in the world's tropical regions, which include Central
and South America, Africa, Asia, the Middle East, and some Pacific islands.
Malaria medication and treatment duration are determined by the type of malaria
and the severity of symptoms. The majority of antimalarial
medications target the stage of infection that causes symptomatic illness.
Pfizer, GlaxoSmithKline Plc., Ranbaxy
Laboratories, Ipca Laboratories Ltd., Zydus Cadila, Merck KGaA, Novartis AG,
Alvizia Health Care, Bayer AG, and Roche Inc. are some of the major market
players in the global anti-malarial drugs market.

Comments
Post a Comment